Home › Cardiomyopathy › North Carolina
Pag-aaral pangklinika para sa Cardiomyopathy sa North Carolina
7 pag-aaral para sa Cardiomyopathy ang naghahanap ng mga kalahok sa mga site sa North Carolina.
Mga Lungsod sa North Carolina
Opisyal na teksto ng pag-aaral (English)
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Charlotte
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07052903DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, Charlotte
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07358078Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
- Duke University Hospital, Durham
Nagre-recruitPhase 2
Edad 0 hanggang 16 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06080074Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Duke University Medical Center, Durham
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06563895Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
- Duke Children's Hospital, Durham
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT07674758MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Duke University Medical Center, Durham
Nagre-recruitPhase 3
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06128629PKP2-ACM Natural History Study
- Duke University, Durham
Nagre-recruitObservasyonal na pag-aaral
Edad 12 pataas · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT06644742Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.